Price T Rowe Associates Inc Inovio Pharmaceuticals, Inc. Transaction History

Price T Rowe Associates Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.38 - $0.58 $26,030 - $39,730	68,500 Added 84.05%	150,000 $59,000
Q2 2023 Aug 14, 2023	SELL	$0.39 - $0.94 $17,419 - $41,985	-44,665 Reduced 35.4%	81,500 $37,000
Q1 2023 May 15, 2023	BUY	$0.79 - $1.91 $24,147 - $58,381	30,566 Added 31.97%	126,165 $104,000
Q4 2022 Feb 14, 2023	SELL	$1.41 - $2.5 $33,660 - $59,682	-23,873 Reduced 19.98%	95,599 $149,000
Q3 2022 Nov 14, 2022	SELL	$1.66 - $2.79 $14,959 - $25,143	-9,012 Reduced 7.01%	119,472 $207,000
Q2 2022 Aug 15, 2022	BUY	$1.44 - $3.98 $4,144 - $11,454	2,878 Added 2.29%	128,484 $222,000
Q1 2022 May 16, 2022	BUY	$2.97 - $5.2 $31,375 - $54,932	10,564 Added 9.18%	125,606 $451,000
Q4 2021 Feb 14, 2022	SELL	$4.99 - $7.46 $243,262 - $363,675	-48,750 Reduced 29.76%	115,042 $574,000
Q3 2021 Nov 15, 2021	BUY	$7.16 - $9.69 $60,860 - $82,365	8,500 Added 5.47%	163,792 $1.17 Million
Q2 2021 Aug 16, 2021	BUY	$6.23 - $10.03 $59,041 - $95,054	9,477 Added 6.5%	155,292 $1.44 Million
Q1 2021 May 17, 2021	SELL	$8.81 - $16.96 $98,398 - $189,426	-11,169 Reduced 7.11%	145,815 $1.35 Million
Q4 2020 Feb 16, 2021	BUY	$8.5 - $12.85 $1.33 Million - $2.02 Million	156,984 New	156,984 $1.39 Million

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $459M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.